Skip to main content
Clinical Trials/NCT05469295
NCT05469295
Completed
N/A

A Prospective, Randomized, Single-blinded, Sham Device Controlled, Parallel Treatment Grouped, Multi-center, Exploratory Clinical Trial to Evaluate Improvement of Cervical Lordosis and Safety of CGM MB-1701 in Subjects With Cervical Kyphosis and Posterior Neck Pain.

Ceragem Clinical Inc.1 site in 1 country30 target enrollmentMay 9, 2023

Overview

Phase
N/A
Intervention
CGM MB-1701 device treatment
Conditions
Cervical Kyphosis
Sponsor
Ceragem Clinical Inc.
Enrollment
30
Locations
1
Primary Endpoint
Mean change of cervical lordosis
Status
Completed
Last Updated
2 months ago

Overview

Brief Summary

The study is a Prospective, Randomized, Single-blinded, Sham device controlled, Parallel Treatment Grouped, Multi-center, Exploratory Clinical Trial to Evaluate Improvement of Cervical Lordosis and Safety of CGM MB-1701 (Spinal warm massage device, Ceragem Master V6) in Subjects with Cervical Kyphosis and Posterior Neck Pain.

Detailed Description

The Cervical Kyphosis are also commonly referred to as "turtle neck syndrome." It refers to the deformation of the neck bone into an inverted C-shape due to abnormalities or degenerative changes, and it is named to mean that the neck is bent like a turtle. This device, Ceragem Master V6 (CGM MB-1701), has been certified as a combination of a personal warmer that can be used to relieve muscle pain by applying constant heat to the human body and a medical vibrator of a device that applies physical energy (vibration, shock, pressure, etc.). Also, the device got approval for use with intermittent pneumatic compression and electrically-powered orthopedics traction. The primary purpose of this clinical trial is to confirm the temporary cervical lordosis angle improvement (height) in subjects with cervical kyphosis through the combined function of the test device.

Registry
clinicaltrials.gov
Start Date
May 9, 2023
End Date
July 26, 2024
Last Updated
2 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Ceragem Clinical Inc.
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Adult male and female subjects who have voluntarily decided to participate and agreed in writing after being briefed on the characteristics of this clinical trial and medical device
  • Subjects with cervical kyphosis angle between cervical lordosis 20 degrees and cervical kyphosis 5 degrees.
  • BMI betweeen 18.5 and 30
  • Chronic neck pain NRS 4 or higher lasting more than 3 months

Exclusion Criteria

  • Secondary spondylosis
  • A tumor of the spine
  • Inflammatory spondylitis
  • Multiple adjacent radiculopathies and others

Arms & Interventions

CGM_MB_1701 treatment

Subjects will be treated with the study device for about 36 minutes.

Intervention: CGM MB-1701 device treatment

Sham (CGM MB1701C) treament

Subjects will be treated with the Sham device for about 36 minutes.

Intervention: CGM MB-1701 Sham device treatment

Outcomes

Primary Outcomes

Mean change of cervical lordosis

Time Frame: up to 16 weeks

Mean change of cervical lordosis using posterior tangent method of Harrison measured by cervical lateral radiography at EOT (End of Trial) compared to baseline.

Secondary Outcomes

  • Cervical vestibular angle increase more than 10 degrees(up to 16 weeks)
  • Anteroposterior (T1) slope average change(up to 16 weeks)
  • Change of cervical lordosis at 2nd interim analysis(up to 16 weeks)

Study Sites (1)

Loading locations...

Similar Trials